Skip to content

Study on the efficacy and safety of 'YiCeng' plaster on pain relief in people with knee osteoarthritis

Effect of synovial tissue nerve fiber production on pain and prognosis in knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043557
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

experimental group:“YiCeng” plaster

Sponsors

Kunshan Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with symptomatic knee osteoarthritis, using the KOA diagnostic criteria in the 2007 edition of the Osteoarthritis Diagnostic and Treatment Guidelines; 2. Patients with painful knee osteoarthritis; 3. Subjects with pain score of at least 30 mm on 100 mm visual analogue scale; 4. Subjects over 40 years old; 5. Subjects who have not used "easy layer" application or Votalin ointment in the past; 6. Subjects who must sign the ICF before the start of the study.

Exclusion criteria

Exclusion criteria: 1. The history of knee trauma or surgery within 6 months before this trial; 2. Arthroscopy or intra-articular injection therapy within 3 months before this trial; 3. Currently participating in other clinical trials; 4. Other concomitant knee diseases, such as rheumatoid arthritis(RA), gouty arthritis, etc. 5. Combination of mental disorders or other diseases that do not accurately describe the symptoms; 6. Combination of other serious diseases, such as severe diabetes,severe liver or kidney disease, malignancy, infectious diseases etc.; 7. History of severe skin allergies; 8. During pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities Arthritis Index scores (WOMAC);visual analog scale (VAS);

Secondary

MeasureTime frame
Knee pain sensitivity threshold;Knee circumference;Skin irritation;Safety;Nerve growth factor;

Countries

China

Contacts

Public ContactPeimin Wang

Kunshan Third People's Hospital

drwpm@163.com+86 13921438618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026